Skip to the catalogue
halfrx

What is Zepbound?

What is Zepbound, and how does it work?

Zepbound (tirzepatide) is a injection made by Eli Lilly, whose active ingredient is tirzepatide. FDA approved for chronic weight management and obstructive sleep apnea It activates two gut-hormone receptors at once — GIP and GLP-1 — which together regulate appetite and how much food is eaten. In its pivotal trial it produced 20.9% mean weight loss. It costs $449 a month once titrated, a figure read from the seller's own page on 2026-08-19 — the maintenance rate rather than the starting dose, because the starting dose is not the dose anyone stays on.

How it works, from the label

It activates two gut-hormone receptors at once — GIP and GLP-1 — which together regulate appetite and how much food is eaten.

Tirzepatide is a GIP receptor and GLP-1 receptor agonist. It contains a C20 fatty diacid that enables albumin binding and prolongs the half-life. Tirzepatide selectively binds to and activates both the GIP and GLP-1 receptors, the targets for native GIP and GLP-1. GLP-1 is a physiological regulator of appetite and caloric intake. Nonclinical studies suggest the addition of GIP may further contribute to the regulation of food intake.

Quoted from the mechanism of action section of FDA prescribing information for ZEPBOUND, read 2026-08-29. Not paraphrased: how a drug works is the last thing a price site should put in its own words.

What it is approved for

  • Chronic weight management

    To reduce excess body weight and maintain weight reduction long term in adults with obesity, or adults with overweight in the presence of at least one weight-related comorbid condition, in combination with a reduced-calorie diet and increased physical activity.

  • Obstructive sleep apnea

    To treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity. This is a separate approved indication, not an off-label use, and it is the one that changes the conversation with a plan that excludes weight-loss drugs.

Which approval a plan cannot exclude — a weight-loss exclusion is written against the use, not the molecule.

What the trial found

20.9% of body weight. SURMOUNT-1: about 20.9% mean weight loss at the 15 mg dose over 72 weeks

One trial, one protocol, one population. Comparing it with another drug's figure compares two separate experiments rather than two drugs — the comparison, and what a point of body weight costs.

It carries a boxed warning — the strongest the FDA issues

In rodents this molecule caused thyroid C-cell tumours at human-relevant doses. Whether it does so in people is unknown, and the label carries that as a boxed warning. It is contraindicated outright with a personal or family history of medullary thyroid carcinoma or MEN 2.

Everything the label lists, including who cannot take it →

What it costs

$449 a month once titrated, read from the seller's own page on 2026-08-19. Definitional pages in this category stop before this line; it is the reason this one exists.

Zepbound price and terms →The cheapest way to get it →

Zepbound, answered

How does Zepbound work?
It activates two gut-hormone receptors at once — GIP and GLP-1 — which together regulate appetite and how much food is eaten. The label's own words, from its mechanism of action section: "Tirzepatide is a GIP receptor and GLP-1 receptor agonist. It contains a C20 fatty diacid that enables albumin binding and prolongs the half-life. Tirzepatide selectively binds to and activates both the GIP and GLP-1 receptors, the targets for native GIP and GLP-1. GLP-1 is a physiological regulator of appetite and caloric intake. Nonclinical studies suggest the addition of GIP may further contribute to the regulation of food intake."
What is Zepbound approved for?
chronic weight management; obstructive sleep apnea. Approvals are quoted from the label rather than summarised, because the wording is what a prior authorisation is judged against — the full text of each is on the indications page.
How much weight did Zepbound lose in its trial?
20.9% of body weight. SURMOUNT-1: about 20.9% mean weight loss at the 15 mg dose over 72 weeks That is what one trial reported under its own protocol, not a prediction for any person, and it cannot be compared directly with another drug's figure because no trial ran them against each other.
How much does Zepbound cost?
$449 a month once titrated, read from the seller's own page on 2026-08-19. The starting dose is usually cheaper and nobody stays on it, which is why the maintenance figure is the one this site records.

Everything on Zepbound

Last updated 2026-08-29 — the FDA label this page quotes